eXoZymes Overview
- Year Founded
-
2019
- Status
-
Public
- Employees
-
32
- Stock Symbol
-
EXOZ
- Investments
-
1
- Share Price
-
$4.00
- (As of Thursday Closing)
eXoZymes General Information
Description
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.
Contact Information
Website
www.exozymes.comCorporate Office
- 750 Royal Oaks Drive
- Suite 106
- Monrovia, CA 91016
- United States
Corporate Office
- 750 Royal Oaks Drive
- Suite 106
- Monrovia, CA 91016
- United States
eXoZymes Timeline
eXoZymes Stock Performance
As of 12-Nov-2026, eXoZymes’s stock price is $4.00. Its current market cap is $37.2M with 9.3M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.00 | $4.00 | $3.24 - $16.90 | $37.2M | 9.3M | 9.5K | -$1.19 |
eXoZymes Financials Summary
As of 30-Jun-2026, eXoZymes has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 77,363 | 87,642 | 161,851 | |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (10,207) | (9,340) | (5,672) | (1,799) |
| Net Income | (10,191) | (9,159) | (5,861) | (2,038) |
| Total Assets | 7,982 | 5,972 | 13,034 | 3,559 |
| Total Debt | 1,085 | 1,243 | 1,387 | 1,612 |
eXoZymes Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
eXoZymes Comparisons
Industry
Financing
Details
eXoZymes Competitors (2)
One of eXoZymes’s 2 competitors is Arzeda, a Venture Capital-Backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arzeda | Venture Capital-Backed | Seattle, WA | ||||
| Codexis | Formerly VC-backed | Redwood City, CA |
eXoZymes Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
eXoZymes Patents
eXoZymes Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025225008-A1 | In vitro synthesis of coenzyme a and acetyl-coa for cell-free biocatalysis | Pending | 22-Feb-2024 | ||
| WO-2025179109-A1 | In vitro synthesis of coenzyme a and acetyl-coa for cell-free biocatalysis | Pending | 22-Feb-2024 | ||
| EP-4720267-A1 | In situ nadp biosynthesis process for biobased chemical production | Pending | 25-May-2023 | ||
| WO-2024243535-A1 | In situ nadp biosynthesis process for biobased chemical production | Inactive | 25-May-2023 | ||
| DE-112024002325-T5 | In-situ nadp biosynthese process for bio-based chemical production | Pending | 25-May-2023 | C12N9/1205 |
eXoZymes Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
eXoZymes Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
eXoZymes Investments (1)
eXoZymes’s most recent deal was a Joint Venture with Joint Venture (Invizyne Technologies / Neuractas Therapeutics). The deal was made on 01-Jun-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Joint Venture (Invizyne Technologies / Neuractas Therapeutics) | 01-Jun-2022 | Joint Venture | Drug Delivery |
eXoZymes ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Chemicals
Industry
Rank
Percentile
Commodity Chemicals
Subindustry
Rank
Percentile
eXoZymes FAQs
-
When was eXoZymes founded?
eXoZymes was founded in 2019.
-
Where is eXoZymes headquartered?
eXoZymes is headquartered in Monrovia, CA.
-
What is the size of eXoZymes?
eXoZymes has 32 total employees.
-
What industry is eXoZymes in?
eXoZymes’s primary industry is Biotechnology.
-
Is eXoZymes a private or public company?
eXoZymes is a Public company.
-
What is eXoZymes’s stock symbol?
The ticker symbol for eXoZymes is EXOZ.
-
What is the current stock price of eXoZymes?
As of 12-Nov-2026 the stock price of eXoZymes is $4.00.
-
What is the current market cap of eXoZymes?
The current market capitalization of eXoZymes is $37.2M.
-
Who are eXoZymes’s competitors?
-
What is eXoZymes’s annual earnings per share (EPS)?
eXoZymes’s EPS for 12 months was -$1.19.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
